Frontage Laboratories Completes Acquisition of Teddy Clinical Research Laboratory (Shanghai)

PharmaLegacy Laboratories Acquires San Diego-Based BTS Research

September 16, 2024

Healthcare Services

PharmaLegacy Laboratories has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO), expanding PharmaLegacy's in vitro and in vivo pharmacology and GLP toxicology capabilities. The acquisition gives PharmaLegacy a local presence in San Diego to increase study capacity and support clients across the United States and North America.

Formosa Laboratories Acquires SynChem to Expand North American CDMO Footprint

June 3, 2024

Pharmaceuticals

Formosa Laboratories, Inc., a Taiwan-based API supplier and CDMO, has completed its acquisition of SynChem, Inc., a contract research laboratory in suburban Chicago. SynChem will operate as SynChem-Formosa with Dr. W. Paul Mar remaining as CEO as the combined operations expand Formosa's US CDMO capabilities for small-molecule APIs and ADC-related chemistries.

AccelLAB Management Acquires AccelLAB from Charles River Laboratories

January 18, 2024

Medical Devices

Key members of AccelLAB's management team acquired AccelLAB from Charles River Laboratories, and the business will operate independently as a standalone preclinical CRO serving the medical device and biologics markets. Fairmount Partners served as exclusive financial advisor to Charles River in the divestiture; AccelLAB employs approximately 100 staff across facilities in Boisbriand and Terrebonne, Quebec, Canada.

Wedgewood Pharmacy Acquires Front Range Laboratories

February 23, 2023

Healthcare Services

Wedgewood Pharmacy acquired Front Range Laboratories (FRL), a Loveland, Colorado-based testing laboratory that provides analytical and microbiological testing to compounding pharmacies. The acquisition, which closed on February 23 (terms undisclosed), brings in FRL's founders Michael and Jennifer Travis to remain with the business and allows Wedgewood to shorten testing turnaround times, better control costs, and increase testing capacity to support growing demand in animal health.

Adare Pharma Solutions Acquires Frontida BioPharm

December 1, 2021

Pharmaceuticals

Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.

Frontage Laboratories Acquires Concord Biosciences

April 5, 2018

Healthcare Services

Frontage Laboratories Inc., a global contract research organization based in Exton, Pennsylvania, acquired Concord Biosciences (formerly Ricerca Biosciences), a preclinical CRO near Cleveland, Ohio. The acquisition adds Concord’s preclinical, toxicology, bioanalytical and agrochemical testing capabilities to Frontage’s early-stage product development services, broadening its service offering across pharmaceutical, agricultural and animal health markets.